Performance promotion
Company announcement
- VOLUNTARY ANNOUNCEMENT ARBITRATION AWARD AGAINST THE COMPANY
- Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 June 2026
- VOLUNTARY ANNOUNCEMENT NDA ACCEPTED BY NMPA FOR THE NEW INDICATION OF ANAPRAZOLE SODIUM FOR THE TREATMENT OF REFLUX ESOPHAGITIS
- VOLUNTARY ANNOUNCEMENT FIRST PATIENT ENROLLED IN PHASE III CLINICAL TRIAL OF ANAPRAZOLE SODIUM FOR HELICOBACTER PYLORI ERADICATION
- LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
- ELECTION OF EMPLOYEE REPRESENTATIVE DIRECTOR
- ARTICLES OF ASSOCIATION
- POLL RESULTS OF THE 2025 ANNUAL GENERAL MEETING AND ABOLISHMENT OF THE SUPERVISORY COMMITTEE AND AMENDMENTS TO THE ARTICLES OF ASSOCIATION
- Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 May 2026
- FORM OF PROXY FOR THE ANNUAL GENERAL MEETING
9th Floor, North Tower of CP Center, No.20 Jin He East Avenue,Chaoyang District,Beijing,China
Tel：010-5765 4567
Email：XZGROUP@xuanzhubio.com
Copyright © 轩竹生物科技有限公司保留所有权利 冀ICP备2020028968号-2 网站建设技术支持：唯引互动
